In the last 12 months, insiders at UroGen Pharma Ltd. ($URGN) filed 138 transactions with the SEC: 0 open-market purchases totaling $0 and 36 sales totaling $1,759,556. Net insider sentiment: net selling.
UroGen Pharma Ltd. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Schoenberg Mark (Chief Medical Officer) — 50 transactions totaling $1,142,679
- Smith Jason Drew (General Counsel) — 41 transactions totaling $579,756
- Degnan Chris (Chief Financial Officer) — 6 transactions totaling $37,121
- Cohen Fred E (Director) — 1 transaction totaling $0
- Barrett Elizabeth A. (Chief Executive Officer) — 4 transactions totaling $0
View all SEC Filings for UroGen Pharma Ltd. (URGN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2025 | Robinson James A. Jr. | Director | M | ordinary shares | 2000 | $0.00 | 4,000.0000 | 47,030,820 | 100.00% | 0.00% |
| Feb. 26, 2025 | Robinson James A. Jr. | Director | M | Restricted Stock Unit | 2000 | $0.00 | 4,000.0000 | 47,030,820 | 33.33% | 0.00% |
| Jan. 31, 2026 | Barrett Elizabeth A. | Chief Executive Officer | A | Restricted Stock Units | 153195 | $0.00 | 153,195.0000 | 48,057,386 | 9999.99% | 0.32% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 48,057,386 | 33.33% | 0.01% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 5500 | $0.00 | 5,500.0000 | 48,057,386 | 50.00% | 0.01% |
| Feb. 3, 2026 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 3217 | $19.69 | 55,588.0000 | 48,057,386 | 5.47% | 0.01% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 5500 | $0.00 | 55,472.0000 | 48,057,386 | 11.01% | 0.01% |
| Feb. 3, 2026 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 2654 | $19.69 | 52,934.0000 | 48,057,386 | 4.77% | 0.01% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 3333 | $0.00 | 58,805.0000 | 48,057,386 | 6.01% | 0.01% |
| Feb. 3, 2026 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1608 | $19.69 | 51,326.0000 | 48,057,386 | 3.04% | 0.00% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 6667 | $0.00 | 49,972.0000 | 48,057,386 | 15.40% | 0.01% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | A | Restricted Stock Units | 32609 | $0.00 | 32,609.0000 | 48,057,386 | 9999.99% | 0.07% |
| Jan. 31, 2026 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 6667 | $0.00 | 0.0000 | 48,057,386 | 100.00% | 0.01% |
| Feb. 3, 2026 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 3686 | $19.69 | 144,985.0000 | 48,057,386 | 2.48% | 0.01% |
| Feb. 3, 2026 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1844 | $19.69 | 150,514.0000 | 48,057,386 | 1.21% | 0.00% |
| Feb. 3, 2026 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1843 | $19.69 | 148,671.0000 | 48,057,386 | 1.22% | 0.00% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3334 | $0.00 | 0.0000 | 48,057,386 | 100.00% | 0.01% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 6666 | $0.00 | 152,358.0000 | 48,057,386 | 4.58% | 0.01% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3334 | $0.00 | 142,359.0000 | 48,057,386 | 2.40% | 0.01% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 48,057,386 | 9999.99% | 0.04% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 145,692.0000 | 48,057,386 | 2.34% | 0.01% |
| Jan. 31, 2026 | Degnan Chris | Chief Financial Officer | A | Restricted Stock Units | 32609 | $0.00 | 32,609.0000 | 48,057,386 | 9999.99% | 0.07% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 6666 | $0.00 | 13,334.0000 | 48,057,386 | 33.33% | 0.01% |
| Jan. 31, 2026 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 48,057,386 | 49.99% | 0.01% |
| Nov. 26, 2025 | BUTITTA CYNTHIA M | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | Robinson James A. Jr. | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | Robinson James A. Jr. | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Nov. 26, 2025 | WEN LEANA | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | WEN LEANA | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Nov. 26, 2025 | Wildman Daniel George | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | Wildman Daniel George | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Nov. 26, 2025 | BUTITTA CYNTHIA M | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Nov. 26, 2025 | Holden Stuart | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | Holden Stuart | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Nov. 19, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 10000 | $25.00 | 139,025.0000 | 48,057,386 | 6.71% | 0.02% |
| Oct. 8, 2025 | Degnan Chris | Chief Financial Officer | M | Restricted Stock Units | 4483 | $0.00 | 8,967.0000 | 48,057,386 | 33.33% | 0.01% |
| Oct. 8, 2025 | Degnan Chris | Chief Financial Officer | M | Ordinary Shares | 4483 | $0.00 | 4,483.0000 | 48,057,386 | 9999.99% | 0.01% |
| Oct. 8, 2025 | Degnan Chris | Chief Financial Officer | S | Ordinary Shares | 2203 | $16.85 | 2,280.0000 | 48,057,386 | 49.14% | 0.00% |
| Sept. 7, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1667 | $0.00 | 149,896.0000 | 47,030,820 | 1.12% | 0.00% |
| Sept. 7, 2025 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 47,030,820 | 49.99% | 0.01% |
| Sept. 8, 2025 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1520 | $19.11 | 43,305.0000 | 47,030,820 | 3.39% | 0.00% |
| Sept. 7, 2025 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 3333 | $0.00 | 44,825.0000 | 47,030,820 | 8.03% | 0.01% |
| Sept. 7, 2025 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1667 | $0.00 | 1,667.0000 | 47,030,820 | 50.00% | 0.00% |
| Sept. 8, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 871 | $19.11 | 149,025.0000 | 47,030,820 | 0.58% | 0.00% |
| Aug. 26, 2025 | Holden Stuart | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Belldegrun Arie | Director | A | Stock Option (right ot buy) | 20000 | $0.00 | 20,000.0000 | 47,030,820 | 9999.99% | 0.04% |
| Aug. 26, 2025 | WEN LEANA | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | WEN LEANA | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | BUTITTA CYNTHIA M | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | BUTITTA CYNTHIA M | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Wildman Daniel George | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Wildman Daniel George | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Robinson James A. Jr. | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Robinson James A. Jr. | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | Holden Stuart | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 11, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 10000 | $17.69 | 148,229.0000 | 47,030,820 | 6.32% | 0.02% |
| July 28, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 163,378.0000 | 47,030,820 | 6.52% | 0.02% |
| July 28, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5149 | $19.14 | 158,229.0000 | 47,030,820 | 3.15% | 0.01% |
| July 28, 2025 | Barrett Elizabeth A. | Chief Executive Officer | A | Performance Stock Units | 87615 | $0.00 | 87,615.0000 | 47,030,820 | 9999.99% | 0.19% |
| July 28, 2025 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 16500 | $0.00 | 49,014.0000 | 47,030,820 | 50.75% | 0.04% |
| July 28, 2025 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 7522 | $19.14 | 41,492.0000 | 47,030,820 | 15.35% | 0.02% |
| June 8, 2025 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 50.00% | 0.02% |
| June 9, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5162 | $7.37 | 153,378.0000 | 47,030,820 | 3.26% | 0.01% |
| June 8, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 158,540.0000 | 47,030,820 | 6.73% | 0.02% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 47,030,820 | 33.33% | 0.01% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1334 | $0.00 | 146,425.0000 | 47,030,820 | 0.92% | 0.00% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 759 | $11.14 | 145,666.0000 | 47,030,820 | 0.52% | 0.00% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 148,999.0000 | 47,030,820 | 2.29% | 0.01% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1896 | $11.14 | 147,103.0000 | 47,030,820 | 1.27% | 0.00% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 150,436.0000 | 47,030,820 | 2.27% | 0.01% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1896 | $11.14 | 148,540.0000 | 47,030,820 | 1.26% | 0.00% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1334 | $0.00 | 0.0000 | 47,030,820 | 100.00% | 0.00% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 47,030,820 | 49.99% | 0.01% |
| Jan. 31, 2025 | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 47,030,820 | 9999.99% | 0.04% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 2500 | $0.00 | 27,726.0000 | 47,030,820 | 9.91% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1258 | $11.14 | 26,468.0000 | 47,030,820 | 4.54% | 0.00% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 6667 | $0.00 | 33,135.0000 | 47,030,820 | 25.19% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 3354 | $11.14 | 29,781.0000 | 47,030,820 | 10.12% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 5500 | $0.00 | 35,281.0000 | 47,030,820 | 18.47% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 2767 | $11.14 | 32,514.0000 | 47,030,820 | 7.84% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 2500 | $0.00 | 0.0000 | 47,030,820 | 100.00% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 6667 | $0.00 | 6,667.0000 | 47,030,820 | 50.00% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 5500 | $0.00 | 11,000.0000 | 47,030,820 | 33.33% | 0.01% |
| Jan. 31, 2025 | Smith Jason Drew | General Counsel | A | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Jan. 31, 2025 | Barrett Elizabeth A. | Chief Executive Officer | A | Restricted Stock Units | 96377 | $0.00 | 96,377.0000 | 47,030,820 | 9999.99% | 0.20% |
| Oct. 8, 2024 | Degnan Chris | Chief Financial Officer | A | Restricted Stock Units | 13450 | $0.00 | 13,450.0000 | 46,779,637 | 9999.99% | 0.03% |
| Oct. 8, 2024 | Degnan Chris | Chief Financial Officer | A | Employee Stock Option (right to buy) | 74142 | $0.00 | 74,142.0000 | 46,779,637 | 9999.99% | 0.16% |
| Sept. 9, 2024 | Kim Dong | Chief Financial Officer | M | Restricted Stock Units | 2500 | $0.00 | 5,000.0000 | 40,501,315 | 33.33% | 0.01% |
| Sept. 9, 2024 | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 2500 | $0.00 | 37,753.0000 | 40,501,315 | 7.09% | 0.01% |
| Sept. 9, 2024 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 40,501,315 | 33.33% | 0.01% |
| Sept. 9, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1521 | $13.08 | 25,226.0000 | 40,501,315 | 5.69% | 0.00% |
| Sept. 9, 2024 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1666 | $0.00 | 145,950.0000 | 40,501,315 | 1.15% | 0.00% |
| Sept. 9, 2024 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1666 | $0.00 | 3,334.0000 | 40,501,315 | 33.32% | 0.00% |
| Sept. 9, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 859 | $13.08 | 145,091.0000 | 40,501,315 | 0.59% | 0.00% |
| Sept. 9, 2024 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 3333 | $0.00 | 26,747.0000 | 40,501,315 | 14.24% | 0.01% |
| Aug. 6, 2024 | Cohen Fred E | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | BUTITTA CYNTHIA M | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | WEN LEANA | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | Robinson James A. Jr. | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | Holden Stuart | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | Wildman Daniel George | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| Aug. 6, 2024 | Belldegrun Arie | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| June 10, 2024 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 149,437.0000 | 37,059,186 | 7.17% | 0.03% |
| June 10, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5153 | $13.08 | 144,284.0000 | 37,059,186 | 3.45% | 0.01% |
| June 10, 2024 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 10000 | $0.00 | 20,000.0000 | 37,059,186 | 33.33% | 0.03% |
| March 18, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 12000 | $14.05 | 139,437.0000 | 36,153,634 | 7.92% | 0.03% |
| March 25, 2022 | Kim Dong | Chief Financial Officer | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 3333 | $0.00 | 35,253.0000 | 36,153,634 | 10.44% | 0.01% |
| Feb. 1, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 3328 | $15.78 | 23,414.0000 | 36,153,634 | 12.44% | 0.01% |
| Feb. 1, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 417 | $15.78 | 18,824.0000 | 36,153,634 | 2.17% | 0.00% |
| Feb. 1, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1248 | $15.78 | 20,076.0000 | 36,153,634 | 5.85% | 0.00% |
| Feb. 1, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1137 | $15.78 | 149,423.0000 | 36,153,634 | 0.76% | 0.00% |
| Feb. 1, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 758 | $15.78 | 149,998.0000 | 36,153,634 | 0.50% | 0.00% |
| Feb. 1, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1894 | $15.78 | 151,437.0000 | 36,153,634 | 1.24% | 0.01% |
| Jan. 31, 2024 | Kim Dong | Chief Financial Officer | A | Restricted Stock Units | 12000 | $0.00 | 12,000.0000 | 36,153,634 | 9999.99% | 0.03% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 834 | $0.00 | 19,241.0000 | 36,153,634 | 4.53% | 0.00% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 417 | $15.74 | 18,824.0000 | 36,153,634 | 2.17% | 0.00% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 2500 | $0.00 | 21,324.0000 | 36,153,634 | 13.28% | 0.01% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 1248 | $15.74 | 20,076.0000 | 36,153,634 | 5.85% | 0.00% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Ordinary Shares | 6666 | $0.00 | 26,742.0000 | 36,153,634 | 33.20% | 0.02% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | S | Ordinary Shares | 3328 | $15.74 | 23,414.0000 | 36,153,634 | 12.44% | 0.01% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 834 | $0.00 | 0.0000 | 36,153,634 | 100.00% | 0.00% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 2500 | $0.00 | 2,500.0000 | 36,153,634 | 50.00% | 0.01% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | M | Restricted Stock Units | 6666 | $0.00 | 13,334.0000 | 36,153,634 | 33.33% | 0.02% |
| Jan. 31, 2024 | Smith Jason Drew | General Counsel | A | Restricted Stock Units | 16500 | $0.00 | 16,500.0000 | 36,153,634 | 9999.99% | 0.05% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 2000 | $0.00 | 150,560.0000 | 36,153,634 | 1.35% | 0.01% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1137 | $15.74 | 149,423.0000 | 36,153,634 | 0.76% | 0.00% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1333 | $0.00 | 150,756.0000 | 36,153,634 | 0.89% | 0.00% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 758 | $15.74 | 149,998.0000 | 36,153,634 | 0.50% | 0.00% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 153,331.0000 | 36,153,634 | 2.22% | 0.01% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1894 | $15.74 | 151,437.0000 | 36,153,634 | 1.24% | 0.01% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 36,153,634 | 100.00% | 0.01% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1333 | $0.00 | 1,334.0000 | 36,153,634 | 49.98% | 0.00% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 36,153,634 | 33.33% | 0.01% |
| Jan. 31, 2024 | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 36,153,634 | 9999.99% | 0.03% |
| Jan. 31, 2024 | Barrett Elizabeth A. | Chief Executive Officer | A | Restricted Stock Units | 87615 | $0.00 | 87,615.0000 | 36,153,634 | 9999.99% | 0.24% |
| Jan. 31, 2024 | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 3333 | $0.00 | 26,585.0000 | 36,153,634 | 14.33% | 0.01% |
| Jan. 31, 2024 | Kim Dong | Chief Financial Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 36,153,634 | 33.33% | 0.01% |